Class information for:
Level 1: REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2536 2144 37.9 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
233 19645 BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REDUCED INTENSITY CONDITIONING Author keyword 81 39% 8% 161
2 DONOR LYMPHOCYTE INFUSION Author keyword 42 38% 4% 88
3 REDUCED INTENSITY Author keyword 40 54% 2% 51
4 GRAFT VERSUS TUMOR EFFECT Author keyword 40 62% 2% 41
5 NONMYELOABLATIVE Author keyword 32 51% 2% 44
6 DONOR LEUKOCYTE INFUSION Author keyword 29 67% 1% 26
7 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Journal 28 10% 12% 265
8 NON MYELOABLATIVE Author keyword 25 52% 2% 34
9 ALLOGENEIC STEM CELL TRANSPLANTATION Author keyword 23 15% 7% 142
10 GRAFT VERSUS LEUKEMIA EFFECT Author keyword 15 34% 2% 36

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 REDUCED INTENSITY CONDITIONING 81 39% 8% 161 Search REDUCED+INTENSITY+CONDITIONING Search REDUCED+INTENSITY+CONDITIONING
2 DONOR LYMPHOCYTE INFUSION 42 38% 4% 88 Search DONOR+LYMPHOCYTE+INFUSION Search DONOR+LYMPHOCYTE+INFUSION
3 REDUCED INTENSITY 40 54% 2% 51 Search REDUCED+INTENSITY Search REDUCED+INTENSITY
4 GRAFT VERSUS TUMOR EFFECT 40 62% 2% 41 Search GRAFT+VERSUS+TUMOR+EFFECT Search GRAFT+VERSUS+TUMOR+EFFECT
5 NONMYELOABLATIVE 32 51% 2% 44 Search NONMYELOABLATIVE Search NONMYELOABLATIVE
6 DONOR LEUKOCYTE INFUSION 29 67% 1% 26 Search DONOR+LEUKOCYTE+INFUSION Search DONOR+LEUKOCYTE+INFUSION
7 NON MYELOABLATIVE 25 52% 2% 34 Search NON+MYELOABLATIVE Search NON+MYELOABLATIVE
8 ALLOGENEIC STEM CELL TRANSPLANTATION 23 15% 7% 142 Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION
9 GRAFT VERSUS LEUKEMIA EFFECT 15 34% 2% 36 Search GRAFT+VERSUS+LEUKEMIA+EFFECT Search GRAFT+VERSUS+LEUKEMIA+EFFECT
10 GRAFT VERSUS LEUKEMIA 15 28% 2% 45 Search GRAFT+VERSUS+LEUKEMIA Search GRAFT+VERSUS+LEUKEMIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEUKOCYTE INFUSIONS 105 61% 5% 112
2 GRAFT VERSUS LEUKEMIA 71 32% 9% 184
3 REDUCED INTENSITY 63 40% 6% 123
4 DONOR LEUKOCYTE INFUSIONS 48 38% 5% 102
5 HOST DISEASE 44 15% 12% 266
6 HEMATOLOGIC MALIGNANCIES 38 12% 15% 311
7 PREPARATIVE REGIMENS 31 44% 3% 54
8 IDENTICAL LITTERMATE DOGS 27 54% 2% 35
9 2ND TRANSPLANTS 23 79% 1% 15
10 HCT CI 23 79% 1% 15

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 28 10% 12% 265

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Graft-versus-leukemia effects of transplantation and donor lymphocytes 2008 222 143 34%
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia 2015 2 80 44%
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma 2004 192 26 46%
Graft-versus-leukemia reactions in allogeneic chimeras 2004 248 101 34%
How I assess comorbidities before hematopoietic cell transplantation 2013 24 26 35%
Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia 2011 19 25 72%
Donor lymphocyte infusions: the long and winding road: how should it be traveled? 2008 45 59 75%
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation 2011 36 119 43%
Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents 2006 67 102 67%
Comparison of Reduced-Intensity and Myeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: A Meta-Analysis 2014 2 51 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DANNY CUNNIFF LEUKEMIA 15 88% 0.3% 7
2 BONE MARROW TRANSPLANTAT CANC IMMUNOTHER 9 29% 1.2% 26
3 CTCG 6 80% 0.2% 4
4 INT BLOOD MARROW TRANSPLANT 6 15% 1.8% 38
5 INVEST CLIN CANCEROL CI2C 6 41% 0.5% 11
6 UTTC 5 45% 0.4% 9
7 UNITE TRANSPLANTAT THER IE CELLULAIRE 5 30% 0.7% 15
8 ALLOGENE STEM CELL TRANSPLANTAT 4 14% 1.4% 29
9 KLIN POLIKLIN KMT 4 75% 0.1% 3
10 PROGRAMME TRANSPLANTAT THER IE CELLULAIRE 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000245805 DONOR CELL LEUKEMIA//CHIMERISM//STR PCR
2 0.0000225603 HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION
3 0.0000179246 BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN
4 0.0000164529 MINOR HISTOCOMPATIBILITY ANTIGENS//MINOR HISTOCOMPATIBILITY ANTIGEN//HA 1
5 0.0000151247 GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD
6 0.0000134397 TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE
7 0.0000120827 MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL
8 0.0000112048 PRAME//LEUKEMIA ASSOCIATED ANTIGENS//UNIT 900
9 0.0000098580 ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML
10 0.0000086332 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA